Switch iconSwitch
Homepage iconHomepage facebook iconfacebook IG iconIG Hospital iconOther Hospital CMUH APP iconCMUH App
About CMUH

News and Award

:::
Home/
About CMUH/
News and Award/
Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

About CMUH

2025/2/17

Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

Authors : 陳柏谷(Po-Ku Chen)、陳一銘(Yi-Ming Chen)、陳建尉 (Jeremy JW Chen)、陳得源 (Der-Yuan Chen)*

Journal : Rheumatology (Oxford)

Publication Date : 2024

Link : https://pubmed.ncbi.nlm.nih.gov/39447044/

回上頁

Related Articles

Nesfatin-1 Stimulates CCL2-dependent Monocyte Migration And M1 Macrophage Polarization: Implications For Rheumatoid Arthritis Therapy img
Nesfatin-1 Stimulates CCL2-dependent Monocyte Migration And M1 Macrophage Polarization: Implications For Rheumatoid Arthritis Therapy
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide img
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide
Biological ageing: a promising target for prevention and management of rheumatoid arthritis. img
Biological ageing: a promising target for prevention and management of rheumatoid arthritis.
Stay connected with CMUH
facebook Facebook
IG
youtube YouTube
How to get to CMUH the map of hospital
Download
▲